Latest News about BEAM
Recent news which mentions BEAM
Breaking Down Beam Therapeutics: 5 Analysts Share Their Views
November 06, 2024
Tickers
BEAM
From Benzinga
From Benzinga
Gene Therapy Developer Beam Therapeutics Reports One Patient Death In Early-Stage Sickle Cell Disease Trial
November 05, 2024
From Benzinga
Deep Dive Into Beam Therapeutics Stock: Analyst Perspectives (6 Ratings)
September 11, 2024
Tickers
BEAM
From Benzinga
A Closer Look at 5 Analyst Recommendations For Beam Therapeutics
August 22, 2024
Tickers
BEAM
From Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
From Benzinga
3 Gene Editing Stocks with Potential to Transform Medicine
August 09, 2024
From InvestorPlace
Tickers
BEAM
From InvestorPlace
From Benzinga
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
July 25, 2024
From Benzinga
Why Is Conn’s (CONN) Stock Down 36% Today?
July 24, 2024
From InvestorPlace
Tickers
BEAM
From InvestorPlace
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
July 23, 2024
From Benzinga
3 Gene Editing Stocks Shaping the Future of Medicine
July 22, 2024
From InvestorPlace
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
July 18, 2024
From Benzinga
From InvestorPlace
3 Stocks With the Potential to 10X Your Money
July 09, 2024
From InvestorPlace
From InvestorPlace
From InvestorPlace
From InvestorPlace
From InvestorPlace
Tickers
BEAM
From InvestorPlace
From Benzinga
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
April 02, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
